Remembering visceral leishmaniasis as a potential trigger of haemophagocytic lymphohistiocytosis in individuals treated with anti-TNF-alpha therapy
Main Article Content
Abstract
Cite this article as: Nardo-Marino A, Bukan K, Vedel Nielsen H, El Fassi D. Remembering visceral leishmaniasis as a potential trigger of haemophagocytic lymphohistiocytosis in individuals treated with anti-TNF-alpha therapy. Eur J Rheumatol 2019; 6(4): 226-7.